Answers are grounded in this paper and cite their sources.
Previous studies indicated that both plasma-derived and recombinant human factor VIIa specifically interacted with tissue factor on the surface of a human bladder carcinoma cell line (J82). In the presence of calcium ions, factor VIIa interacted with approximately 300,000 binding sites/cell with a dissociation constant (Kd) of 3.25 nM (Sakai, T., Lund-Hansen, T., Paborsky, L., Pedersen, A. H., and Kisiel, W. (1989) J. Biol. Chem. 264, 9980-9988). In this study, we compare recombinant human factor VIIa and a preparation of recombinant human factor VIIa lacking the gamma-carboxyglutamic acid domain (GD-rVIIa) with respect to their interaction with J82 cell surface tissue factor. Interaction of GD-rVIIa with J82 monolayers at 37 degrees C was specific, saturable, and exhibited a hyperbolic profile. Scatchard plots of the binding data obtained at 37 degrees C indicated a single class of binding sites for GD-rVIIa with a Kd value of 2.5 nM. GD-rVIIa interacted with about 10,000 binding sites/cell. In contrast to the tissue factor-specific binding observed for intact factor VIIa, specific binding of GD-rVIIa to the J82 cell surface was neither influenced by calcium nor blocked by prior incubation of the cells with polyclonal anti-tissue factor apoprotein IgG. In addition, cell-bound GD-rVIIa failed to activate human factor X. These results indicate that the gamma-carboxyglutamic acid domain of factor VIIa is essential for its interaction with cell surface tissue factor.
No takes yet. Share an insight, caveat, or question.
Sakai et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: